EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in gene therapy for bone tissue engineering

Fatemeh Ranjbarnejad, Mozafar Khazaei, Alireza Shahryari, Fatemeh Khazaei, Leila Rezakhani iD

Journal of Tissue Engineering and Regenerative Medicine · 2022-12 · 16 (12) · 1121-1137

DOI: 10.1002/term.3363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, online erschienen am 16.11.2022. Verfasst von Fatemeh Ranjbarnejad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Tissue Engineering, Genetic Therapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Kermanshah University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autografting, a major treatment for bone fractures, has potential risks related to the required surgery and disease transmission. Bone morphogenetic proteins (BMPs) are the most common osteogenic factors used for bone-healing applications. However, BMP delivery can have shortcomings such as a short half-life and the high cost of manufacturing the recombinant proteins. Gene delivery methods have demonstrated promising alternative strategies for producing BMPs or other osteogenic factors using engineered cells. These approaches can also enable temporal overexpression and local production of the therapeutic genes in the target tissues. This review addresses recent progress on engineered viral, non-viral, and RNA-mediated gene delivery systems that are being used for bone repair and regeneration. Advances in clustered regularly interspaced short palindromic repeats/Cas9 genome engineering for bone tissue regeneration also is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringGenetic TherapyGene Transfer TechniquesBone RegenerationBone Morphogenetic Proteins

Stichwörter der Autor:innen

CRISPR/Cas9bone lossgene therapytissue engineeringviral gene delivery

Substanzen

Bone Morphogenetic Proteins

Autor:innen und Institutionen

  • Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Tissue Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Tools for Bio-Imaging, Max-Planck-Institute for Biological Intelligence, Martinsried, Germany.
  • Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.

ORCID-Profile: Leila Rezakhani

Förderung

  • Kermanshah University of Medical Sciences

Zitieren

APA

Ranjbarnejad, F., Khazaei, M., Shahryari, A., Khazaei, F., & Rezakhani, L. (2022). Recent advances in gene therapy for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 16(12), 1121-1137. https://doi.org/10.1002/term.3363

Vancouver

Ranjbarnejad F, Khazaei M, Shahryari A, Khazaei F, Rezakhani L. Recent advances in gene therapy for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(12):1121-1137. doi:10.1002/term.3363

BibTeX
@article{Ranjbarnejad2022,
  author = {Ranjbarnejad, Fatemeh and Khazaei, Mozafar and Shahryari, Alireza and Khazaei, Fatemeh and Rezakhani, Leila},
  title = {Recent advances in gene therapy for bone tissue engineering},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {12},
  pages = {1121--1137},
  doi = {10.1002/term.3363}
}
Kostenlos starten →